Department of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, 677 Huntington Avenue, Boston, MA, USA.
Leonard Davis School of Gerontology, University of Southern California, 3715 McClintock Avenue, Los Angeles, CA, USA.
Psychol Med. 2022 Oct;52(13):2510-2519. doi: 10.1017/S0033291720004390. Epub 2020 Dec 3.
Studies evaluating depression's role in lung cancer risk revealed contradictory findings, partly because of the small number of cases, short follow-up periods, and failure to account for key covariates including smoking exposure. We investigated the association of depressive symptoms with lung cancer risk in a large prospective cohort over 24 years while considering the role of smoking.
Women from the Nurses' Health Study completed measures of depressive symptoms, sociodemographics, and other factors including smoking in 1992 ( = 42 913). Depressive symptoms were also queried in 1996 and 2000, whereas regular antidepressant use and physician-diagnosed depression were collected starting in 1996. Multivariable Cox regression models estimated hazard ratios (HRs) and 95% confidence intervals (CIs) of lung cancer risk until 2016.
We identified 1009 cases of lung cancer. Women with the highest lowest level of depressive symptoms had an increased lung cancer risk (HR = 1.62, 95% CI 1.34-1.95; HR = 1.25, 95% CI 1.04-1.51). In a test of mediation, lifetime pack-years of smoking accounted for 38% of the overall association between depressive symptoms and disease risk. When stratifying by smoking status, the elevated risk was evident among former smokers but not current or never smokers; however, the interaction term suggested no meaningful differences across groups ( = 0.29). Results were similar or stronger when considering time-updated depression status (using depressive symptoms, physician diagnosis, and regular antidepressant use) and chronicity of depressive symptoms.
These findings suggest that greater depressive symptoms may contribute to lung cancer incidence, directly and indirectly via smoking habits, which accounted for over a third of the association.
评估抑郁症状在肺癌风险中的作用的研究结果存在矛盾,部分原因是病例数量少、随访时间短,以及未能考虑包括吸烟暴露在内的关键协变量。我们在 24 年的时间里,通过考虑吸烟的作用,在一个大型前瞻性队列中研究了抑郁症状与肺癌风险之间的关联。
1992 年(n = 42913),参加护士健康研究的女性完成了抑郁症状、社会人口统计学和其他因素(包括吸烟)的评估。1996 年和 2000 年也询问了抑郁症状,而从 1996 年开始收集定期使用抗抑郁药和医生诊断的抑郁症的信息。多变量 Cox 回归模型估计了肺癌风险的风险比(HR)和 95%置信区间(CI),直至 2016 年。
我们确定了 1009 例肺癌病例。抑郁症状最高/最低水平的女性肺癌风险增加(HR = 1.62,95%CI 1.34-1.95;HR = 1.25,95%CI 1.04-1.51)。在中介检验中,终生吸烟包年数解释了抑郁症状与疾病风险之间总体关联的 38%。按吸烟状况分层时,这种风险在以前吸烟者中明显,但在当前或从不吸烟者中不明显;然而,交互项表明各组之间没有显著差异(= 0.29)。当考虑时间更新的抑郁状况(使用抑郁症状、医生诊断和定期使用抗抑郁药)和抑郁症状的慢性时,结果相似或更强。
这些发现表明,更多的抑郁症状可能直接或通过吸烟习惯间接导致肺癌发病率增加,吸烟习惯占关联的三分之一以上。